Cardiotoxicity of cancer therapy.
Tolba
K A
KA
Division of Hematology-Oncology, University of Rochester, New York, USA.
Deliargyris
E N
EN
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000139:chemically induced*; D016207:Cytokines / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D009206:Myocardium / Q000473:pathology*; D009369:Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy
D000970:Antineoplastic Agents; D016207:Cytokines